Aclasta 5mg/100ml Infusion
Marketer
Novartis India Ltd
Salt Composition
Zoledronic acid (5mg/100ml)
Overview Aclasta 5mg/100ml Infusion
Zoledronic acid 5mg/100ml infusion is administered to manage or prevent bone fragility (osteoporosis) resulting from menopause or steroid use. This medication lowers fracture risk. It also treats hypercalcemia in cancer patients. Infusion is administered by a healthcare professional. Dosage and frequency are determined by your physician, ranging from a single dose to a series of injections based on your condition. Pre-injection hydration is crucial to prevent dehydration. Full therapeutic effects may take several days. This treatment is part of a comprehensive program potentially including dietary adjustments and calcium/vitamin supplementation. Common side effects involve nausea, tiredness, anemia, bone pain, fever, and vomiting. Serious kidney complications can arise, particularly with dehydration, diuretic use, or pre-existing kidney disease. Hypocalcemia and temporomandibular pain are also possible serious side effects requiring immediate medical attention. Report any such symptoms immediately. This medication is contraindicated during pregnancy and breastfeeding. Disclose any kidney issues or low calcium levels before treatment, as well as all other medications, especially those for serious infections, cancer, or osteoporosis, as interactions may occur. Regular monitoring of kidney function and calcium levels is necessary. Smoking and excessive alcohol consumption should be avoided due to their negative impact on bone health and increased fracture risk.
Uses of Aclasta 5mg/100ml Infusion
Elevated blood calcium levels|Bone fragility
Major Benefits of Aclasta 5mg/100ml Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Aclasta 5mg/100ml Infusion:
- Headache
- Back pain
- Musculoskeletal (bone, muscle or joint) pain
- Heartburn
- Diarrhea
- Fever
- Anemia (low number of red blood cells)
- Fatigue
- Bone pain
- Nausea
- Vomiting
How to use Aclasta 5mg/100ml Infusion:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Aclasta 5mg/100ml Infusion works:
Zoledronic acid 5mg/100ml infusion, a bisphosphonate medication, inhibits osteoclast activity, thereby reducing bone breakdown. This leads to stronger bones and a decreased fracture risk.
SAFETY ADVICE
AlcoholCAUTION
Aclasta 5mg/100ml Infusion should be used cautiously with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Zoledronic acid 5mg/100ml infusion poses a confirmed risk to a fetus and should not be administered during pregnancy. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Aclasta 5mg/100ml infusion while breastfeeding is likely unsafe. Preliminary data from human studies indicate potential drug transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Administering Aclasta 5mg/100ml intravenously can induce drowsiness, visual disturbances, or dizziness. Refrain from driving if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Aclasta 5mg/100ml Infusion to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Aclasta 5mg/100ml infusion to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Aclasta 5mg/100ml Infusion :
Omitting a scheduled Aclasta 5mg/100ml infusion requires immediate physician consultation.
Facts to Know About Aclasta 5mg/100ml Infusion
| Label | Value |
|---|---|
| Chemical Type | Bisphosphonate Analog |
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
3,018 People bought this recently